1. Home
  2. ORKA vs AN Comparison

ORKA vs AN Comparison

Compare ORKA & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$94.55

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo AutoNation Inc.

AN

AutoNation Inc.

HOLD

Current Price

$169.61

Market Cap

6.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORKA
AN
Founded
2004
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.9B
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
ORKA
AN
Price
$94.55
$169.61
Analyst Decision
Strong Buy
Buy
Analyst Count
12
9
Target Price
$92.50
$244.33
AVG Volume (30 Days)
737.6K
509.7K
Earning Date
05-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.71
EPS
N/A
11.26
Revenue
N/A
$27,631,400,000.00
Revenue This Year
N/A
$4.32
Revenue Next Year
N/A
$2.89
P/E Ratio
N/A
$14.99
Revenue Growth
N/A
3.24
52 Week Low
$14.89
$165.14
52 Week High
$115.52
$235.81

Technical Indicators

Market Signals
Indicator
ORKA
AN
Relative Strength Index (RSI) 46.43 25.87
Support Level $83.25 N/A
Resistance Level $97.02 $213.50
Average True Range (ATR) 4.53 7.89
MACD -0.01 -4.24
Stochastic Oscillator 53.22 12.94

Price Performance

Historical Comparison
ORKA
AN

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its programs are to treat and potentially modify disease by targeting mechanisms with efficacy and safety involved in disease pathology and the activity of pathogenic tissue-resident memory T cells (TRMs). Its program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, hidradenitis suppurativa (HS), psoriatic arthritis (PsA), and other conditions.

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 245 dealerships, plus 52 collision centers. The firm also has 24 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which proved to be a smart move.

Share on Social Networks: